rs2267703

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001061.7(TBXAS1):​c.1135-19107G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.364 in 151,926 control chromosomes in the GnomAD database, including 10,982 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.36 ( 10982 hom., cov: 31)

Consequence

TBXAS1
NM_001061.7 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0900

Publications

3 publications found
Variant links:
Genes affected
TBXAS1 (HGNC:11609): (thromboxane A synthase 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. The enzyme plays a role in several pathophysiological processes including hemostasis, cardiovascular disease, and stroke. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
TBXAS1 Gene-Disease associations (from GenCC):
  • ghosal hematodiaphyseal dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001061.7, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.761 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001061.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBXAS1
NM_001061.7
MANE Select
c.1135-19107G>A
intron
N/ANP_001052.3P24557-1
TBXAS1
NM_001166253.4
c.1273-19107G>A
intron
N/ANP_001159725.2P24557-3
TBXAS1
NM_001130966.5
c.1135-19107G>A
intron
N/ANP_001124438.2P24557-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBXAS1
ENST00000448866.7
TSL:1 MANE Select
c.1135-19107G>A
intron
N/AENSP00000402536.3P24557-1
TBXAS1
ENST00000336425.10
TSL:1
c.1135-19107G>A
intron
N/AENSP00000338087.7P24557-1
TBXAS1
ENST00000425687.5
TSL:1
c.934-19107G>A
intron
N/AENSP00000388736.1P24557-2

Frequencies

GnomAD3 genomes
AF:
0.364
AC:
55260
AN:
151808
Hom.:
10955
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.344
Gnomad AMI
AF:
0.416
Gnomad AMR
AF:
0.535
Gnomad ASJ
AF:
0.259
Gnomad EAS
AF:
0.781
Gnomad SAS
AF:
0.235
Gnomad FIN
AF:
0.353
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.321
Gnomad OTH
AF:
0.395
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.364
AC:
55313
AN:
151926
Hom.:
10982
Cov.:
31
AF XY:
0.370
AC XY:
27478
AN XY:
74250
show subpopulations
African (AFR)
AF:
0.344
AC:
14239
AN:
41414
American (AMR)
AF:
0.536
AC:
8188
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.259
AC:
897
AN:
3466
East Asian (EAS)
AF:
0.782
AC:
4013
AN:
5134
South Asian (SAS)
AF:
0.235
AC:
1132
AN:
4812
European-Finnish (FIN)
AF:
0.353
AC:
3721
AN:
10544
Middle Eastern (MID)
AF:
0.235
AC:
69
AN:
294
European-Non Finnish (NFE)
AF:
0.321
AC:
21822
AN:
67956
Other (OTH)
AF:
0.404
AC:
854
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1693
3385
5078
6770
8463
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.337
Hom.:
28858
Bravo
AF:
0.387
Asia WGS
AF:
0.530
AC:
1839
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
1.1
DANN
Benign
0.63
PhyloP100
-0.090
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2267703;
hg19: chr7-139687783;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.